Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558128 · ClinicalTrials.gov registry record · NA
Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01558128: Clinical Trial NA study, sponsored by Weill Medical College of Cornell University.
NCT01558128 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01558128, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To determine the efficacy of cardioversion and amiodarone for cardiac patients who develop postoperative atrial fibrillation
Primary Outcome
Measuring change from baseline cardiac rhythm.
Interventions
- DRUG Amiodarone
- PROCEDURE Cardioversion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-03 |
| Phase | NA |
Why NCT01558128 stopped before completion
NCT01558128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Amiodarone is the first listed.
NCT01558128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01558128 about?
NCT01558128 is a clinical study titled "Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery". To determine the efficacy of cardioversion and amiodarone for cardiac patients who develop postoperative atrial fibrillation
What is the current status of trial NCT01558128?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2012-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01558128?
The interventions under investigation include: Amiodarone (DRUG), Cardioversion (PROCEDURE).
Who is sponsoring clinical trial NCT01558128?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01558128's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia